Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Itau Unibanco Holding: Q4 Earnings Insights

Itau Unibanco Holding (NYSE:ITUB) reported its Q4 earnings results on Monday, February 5, 2024 at 04:00 PM. Here’s…
byBenzinga Insights
February 5, 2024
1 minute read
Total
0
Shares
0
0
0
0
0
0

Itau Unibanco Holding (NYSE:ITUB) reported its Q4 earnings results on Monday, February 5, 2024 at 04:00 PM.

Here’s what investors need to know about the announcement.

Earnings

Itau Unibanco Holding reported in-line EPS of $0.19 versus an estimate of $0.19.

Revenue was up $1.08 billion from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.0 which was followed by a 3.67% increase in the share price the next day.

Here’s a look at Itau Unibanco Holding’s past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate 0.19 0.17 0.17 0.16
EPS Actual 0.19 0.18 0.16 0.15
Revenue Estimate 8.34B 7.61B 7.41B 7.03B
Revenue Actual 8.10B 8.11B 7.21B 7.20B

To track all earnings releases for Itau Unibanco Holding visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Organic Growth And Innovation Drive YoY Increase In Cannabis Producer Organigram’s Q4 Revenue And Adjusted EBITDA

By Jelena Martinovic
December 19, 12:41 PM
Canadian cannabis producer Organigram Holdings reported an 11% year-over-year increase in net revenue for the fourth quarter, reaching C$A161.6 million ($121 million). The company credited the growth to its focus on innovative products that meet consumer demand for convenience, such as pre-rolls and edibles. The increase in revenue contributed to a 71% rise in adjusted EBITDA to nearly CA$6m for the quarter, compared with the same period in 2022. Organigram's adjusted gross margin was CA$40.2m, up 20% on 2022. The company also reported a net loss of CA$248.6m, compared with CA$14.3m in 2022, due to impairments on property, plant and equipment, intangibles and goodwill. Organigram said it expects improved margins in future as efficiency gains from facility upgrades and expansion into higher-margin categories such as craft flower and vapes bear fruit.

OGI